Aberrant Collagen Cross-linking in Human Oral Squamous Cell Carcinoma

DOI Web Site Web Site 5 Citations
  • T. Saito
    Department of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital, Chiba, Japan
  • K. Uzawa
    Department of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital, Chiba, Japan
  • M. Terajima
    Department of Oral and Craniofacial Health Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
  • M. Shiiba
    Department of Medical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan
  • A.L. Amelio
    Department of Oral and Craniofacial Health Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
  • H. Tanzawa
    Department of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital, Chiba, Japan
  • M. Yamauchi
    Department of Oral and Craniofacial Health Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

Description

<jats:p> Tumor progression is a complex process involving extracellular matrix (ECM) remodeling and stiffening. However, the mechanisms that govern these processes and their roles in tumor progression are still poorly understood. In this study, we performed bioinformatics, immunohistochemical, and biochemical analyses to examine if collagen cross-linking is associated with tumor stage and regional lymph node metastasis (RLNM) in oral squamous cell carcinoma (OSCC). We found that the genes encoding key enzymes for cross-linking are frequently overexpressed in oral, head, and neck cancers. Specifically, the enzymes lysyl hydroxylase 2 (LH2) or lysyl oxidase (LOX) and LOX-like 2 (LOXL2) were significantly upregulated in late-stage tumors and associated with poor patient prognosis. The protein levels of these enzymes in the primary human OSCC were also significantly increased in late-stage tumors and markedly elevated in the RLNM-positive tumors. Notably, while overall LOX/LOXL2-catalyzed collagen cross-links were enriched in late-stage and RLNM-positive tumors, LH2-mediated stable cross-links were significantly increased. To our knowledge, this is the first study to investigate the association of collagen cross-linking and expression of key enzymes regulating this process with OSCC stage. The data indicate a critical role for collagen cross-linking in OSCC tumor progression and metastasis, which may provide insights into development of novel therapeutic strategies to prevent OSCC progression. </jats:p>

Journal

Citations (5)*help

See more

Report a problem

Back to top